Objectives: To conduct a pilot study assessing a neonatologist's accuracy in diagnosing patent ductus arteriosus (PDA) using compact, portable ultrasound after limited training.
Introduction
Patent ductus arteriosus (PDA) in premature infants is an associated factor in serious neonatal morbidities, associated with increased risk of necrotizing enterocolitis, intraventricular hemorrhage, bronchopulmonary dysplasia and pulmonary hemorrhage. [1] [2] [3] [4] [5] In a review of periventricular leukomalacia in preterm infants, PDA was associated with decreased cerebellar volume, area of the vermis and diameter of the pons. 6 The frequency of PDA is high in premature infants, ranging from 53% in infants born before 34-weeks gestation, up to 65% in infants born before 26-weeks gestation. 7, 8 PDA in preterm infants often requires pharmacologic or surgical closure. Treatment of PDA has been shown to improve pulmonary function, including increase in dynamic compliance, tidal volume and minute ventilation. 9 Early pharmacological treatment has also been shown to reverse low renal and splanchnic blood flow in infants with PDA. 10 Although there are clinical signs for diagnosis of PDA including auscultation of a cardiac murmur, bounding pulses and wide pulse pressure, studies have shown that physical exam is inadequate in detecting significant PDAs in preterm infants. [11] [12] [13] The current standard of care for diagnosis of PDA is an echocardiogram, yet echocardiography is not routinely taught to neonatologists. Nevertheless, it has been suggested that patient care could be improved in the neonatal intensive care unit (NICU) if neonatologists were trained in echocardiography. 14 Advances in technology are allowing echocardiography to be performed by nontraditional personnel in certain settings. Ultrasound technology has become more compact, allowing use as a point-of-care diagnostic tool. A handheld ultrasound was found to be effective in the diagnosis of congenital heart disease, including PDA. 15 In this series, the interpreters were experienced echocardiographers. Such devices are being utilized in settings such as the emergency department and surgical ICUs where a quick, focused evaluation could benefit the patient. 16 Neonatal units may also benefit from small handheld ultrasound devices for assessment of umbilical line placement and cerebral blood flow.
We performed a pilot study to assess the potential utility of a limited training program to diagnose PDA for a neonatologist with no cardiology background. We used a portable ultrasound machine, one which could potentially be used in small NICUs without ready access to a pediatric cardiologist.
Methods
This was a prospective, masked pilot study of the accuracy of PDA diagnosis by neonatologist-performed compact ultrasound exam compared with routine echocardiography. This pilot study was approved by the Stanford University Institutional Review Board.
The 'routine echocardiogram' was the exam ordered by the medical team taking care of the patient for clinical indications. This exam was performed by an experienced technologist or pediatric cardiologist using the Acuson Sequoia (Siemens USA, Malvern, PA, USA), the primary device used by the pediatric cardiology service in our institution.
The 'study exam' was performed by a neonatologist who underwent training in echocardiography, focusing on diagnosis of PDA; no other neonatologists were trained. This exam was performed with the Acuson Cypress (Siemens USA), a portable ultrasound machine, approximately the size of a briefcase, with fewer advanced capabilities than the Sequoia, but with features such as Doppler and M-mode. The standard Cypress neonatal probe was used at a frequency of 7.5 MHz. The training process included instruction on the working of the ultrasound machine, application of the transducer to the various sites on the patient, addition of Doppler techniques, and pulsed continuous wave to denote magnitude of shunting. Five factors were considered as criteria for diagnosis of a patent ductus: (1) left atrial size assessed from the aortic root and the left atrial aortic root relation, (2) left ventricular size and function, (3) Color Doppler estimate of ductus size at the point of the vena contracta (the narrowest portion of the flow jet), (4) the velocity and character of the ductus Doppler signal, and (5) the amount of retrograde abdominal flow. The training included visualization of the parasternal long axis view, the parasternal short axis view to visualize pulmonary arteries, apical four-chamber view, subcostal view and suprasternal views, including the ductus cut. 17 Using this information, the neonatologist made a determination of patent ductus if the color Doppler views indicated shunting across the ductus. Pulse wave Doppler in the descending aorta was used to augment the diagnosis. A subjective determination of ductal size was made (small, moderate or large) based on this information.
The total training experience consisted of 2 h of lecture including recorded tapes, observation of eight exams by experienced technicians, and three practice exams with guidance on real patients. Approximately 50% of these evaluations had PDA. The total training time was approximately 8 h. Midway through the study, the study cardiologist reviewed the study exams already done with the neonatologist for 1 h.
Subjects
Patients in the NICU who were undergoing evaluation only for suspected PDA, with birth weight 401 to 2000 g or <34-weeks gestational age were eligible for this pilot study. The period of enrollment was from January to July 2005. Infants were excluded if the treating physician decided that the patient should not be enrolled for any reason, the scheduled echocardiogram would be performed before the study exam could be completed, or if the trained neonatologist was unavailable to perform the study exam. Informed consent was obtained for all patients who participated in the study.
On some occasions, an infant received more than one echocardiogram to follow-up on the status of PDA. For these infants, the study exam could be repeated for a maximum of two times, before each routine echocardiogram.
Procedure
Enrolled patients underwent the study exam consisting of a compact, portable ultrasound exam (Acuson Cypress, Siemens USA) by the study neonatologist before the routine echocardiogram performed by pediatric cardiology. Using the information as outlined previously, the neonatologist made a determination of patent ductus if color Doppler views indicated shunting across the ductus. A subjective determination of ductal size was made: small, moderate or large. Results of the study exam were not revealed to caregivers, cardiologists or families and did not influence treatment decisions. No clinical actions were based on these study results. These results were noted on a dated and timed confidential study form immediately after the study exam, and sent to two different confidential electronic email accounts, to assure they would not be amended. The neonatologist recorded the patency of the ductus, and if patent, an interpretation of the size of the ductus.
The primary outcome variable to be measured was the accuracy of the diagnosis of PDA by the neonatologist using the compact, portable ultrasound machine. The routine exam performed by the pediatric cardiology service was considered the gold standard for diagnosis. In general, this exam was performed by a skilled pediatric echocardiography technician or member of the pediatric cardiology staff or faculty, and subsequently interpreted by a pediatric cardiologist. None of these practitioners knew the results of the study exam.
The study exams were recorded on electronic media and later reviewed in a masked fashion by a cardiologist who was not familiar with the patients in the study. This cardiologist knew neither the study exam interpretation by the neonatologist, nor the routine exam interpretation by the pediatric cardiologist. The study cardiologist interpreted the study exams and also graded the quality of the exams in a subjective fashion. For some selected study exams in which there were discrepancies between the study exam results and the routine exam, the study cardiologist also reviewed the routine exam.
Data analysis
Sensitivities and specificities with 95% confidence intervals of the neonatologist's study exam compared with the routine echocardiogram were calculated. After the primary analysis, we also looked at the diagnosis of moderate or large PDAs as determined by the routine exam.
We also calculated sensitivity and specificity of the study cardiologist's interpretation of the study exam performed by the neonatologist compared with the routine echocardiogram results, again with the routine echocardiogram considered as the gold standard. The study cardiologist was masked to both the neonatologist's interpretation of the study exam, and the formal interpretation of the routine echocardiogram performed by the pediatric cardiology service.
Results
There were 24 exams performed on a total of 14 patients (Table 1 ). All study exams were performed before the routine echocardiogram performed by the cardiology service. Study exams were performed within six h of the cardiology exam for 20 of the studies. Two study exams occurred 9 h before (exam no. 2) and 23 h before (exam no. 10) the cardiology exam. The exact timing of the cardiology exam for two of the studies was unable to be determined (exams nos. 19 and 21). The study cardiologist did not routinely go over the routine exams by the pediatric cardiology service that correlated with the study exams. However, on one occasion, when the cardiologist saw a PDA in the study exam for which the cardiology service had reported no PDA, he reviewed both studies and his interpretation of both the study exam and the routine exam was the presence of a small PDA (exam no. 8).
Compared to the routine echocardiogram, the study exam as interpreted by the neonatologist had 69% sensitivity (95% CI, 44 to 86%) and 88% specificity (95% CI, 53 to 98%) ( Table 2 ). The positive predictive value was 92%, whereas the negative predictive value was 58%. In the five cases where the neonatologist interpreted the study exam as negative when the routine cardiology evaluation Diagnosis of PDA by a Neonatologist HC Lee et al was positive for PDA, three of those five cases had PDAs which were considered small or tiny (Table 1) . Six PDAs were considered to be small or tiny by echocardiogram performed by the cardiology service; if these exams were excluded, the sensitivity was 78% (45 to 94%) and specificity 88% (53 to 98%) ( Table 3 ). The sensitivity and specificity of the masked cardiologist interpretation of the study exam compared with the routine echocardiogram were also determined ( Table 4) . Two of the studies were deemed uninterpretable owing to poor quality. The study cardiologist interpretation of the remaining 22 studies had sensitivity of 87% (62 to 96%) and specificity 71% (36 to 92%).
Discussion
In our pilot study, we found that a neonatologist with very limited training in echocardiography was able to detect PDA in preterm infants with moderate sensitivitiy and specificity using a portable, compact ultrasound device; accuracy improved further when considering only moderate to large PDAs. A cardiologist interpreting the study exams had slightly better success than the neonatologist. These preliminary findings in a small number of patients suggest that a more intensive training program, perhaps with integration of real-time evaluation techniques, could result in further diagnostic improvement. Although such a program may not be necessary in hospitals with pediatric cardiologists and technicians, it may be an appropriate and feasible approach for institutions without this consistent on-site availability. This is the first study describing the training of a neonatologist to interpret ultrasound for the diagnosis of PDA. A previous study looked at echocardiography by a neonatologist of infants suspected to have congenital heart disease. In that study, the cardiologist interpretation was not considered a true gold standard, and a Cohen's kappa of 0.84 of overall agreement was reported. 18 If the cardiologist interpretation had been considered the gold standard, the sensitivity of the neonatologist's exam would have been 75%.
Technological advancements have made ultrasound devices more readily available and portable. A recent study found that a handheld ultrasound device had utility in diagnosing valvular regurgitation in adults. 19 Ultrasounds are being performed increasingly by nontraditional practitioners, such as nurses in obstetrics, trauma surgeons and emergency physicians. [20] [21] [22] [23] By using telephone lines, real-time transmission of echocardiography can be performed. Some NICUs are taking advantage of this technology, in which a cardiologist guides a technician to perform the study, then interprets the study from a distance. 24 In that series, 182 of the 500 exams performed were for suspected PDA. There may be practicing neonatologists who do perform echocardiography in their NICUs for the diagnosis of PDA, particularly in situations when a cardiologist is not available. However, we are not aware of any previous studies reporting training regimens, accuracy or reliability of neonatologistperformed exams using a portable bedside device.
There were several limitations to this study. The methodology included several factors, any or all of which may have effected the study results: (1) the use of a smaller portable ultrasound device as compared to the more sophisticated machine used by the cardiology service, (2) the fact that only one neonatologist performed the study exams, and (3) the training process. The images on the portable device were not as clear as the usual machine. However, it did feature the ability to perform Doppler ultrasound and the large majority of exams were considered sufficient by the study cardiologist. We may have seen different results had more than one neonatologist performed the study exams. However, the device was available for use on a limited basis and it was not practical for more than one person to perform the studies. It may be the case that another neonatologist with the same training and similar patients may have performed differently. We reviewed the two cases (nos. 13 and 21) in which the study neonatologist missed the diagnosis of a large PDA. Both study exams by the neonatologist were technically competent with clear views of the PDA on several views, retrograde abdominal aorta flow. The study cardiologist (and in retrospect, the study neonatologist) visualized a large PDA in both studies. We attribute the missed diagnoses to lack of experience and confidence on the part of a novice interpreting the exams.
A longer training program may also have allowed for improved diagnosis of PDA. We tried to simulate a relatively short, 1-2 days training program that would allow participation by a busy neonatologist, in a setting where direct supervision would likely be unavailable after the training program. The training involved education in learning how to use the ultrasound device itself, learning the various views, and the nuances of the diagnosis of PDA in a very small infant. We found that the neonatologist had room for improvement in both the technical skills of echocardiography as well as interpretation of exams to diagnose PDA.
There can also be some subjectivity in the interpretation of echocardiograms. In our study, we reviewed one particular patient who had a PDA seen in the study exam by both the neonatologist and study cardiologist (exam no. 8). Although the practicing cardiologist's interpretation of the routine exam in that circumstance had been no PDA, the study cardiologist interpreted the routine exam as positive for PDA. However, practically speaking, most clinicians would consider that echocardiography is the gold standard for diagnosis of PDA.
In summary, we found that, even with extremely limited training, a neonatologist was able to detect PDA with moderate success. A more rigorous training process or real-time transmission with cardiologist interpretation and guidance could improve accuracy and thus avoid inappropriate patient treatment.
